Application of Virus-Like Particles for Cell-Specific Drug Delivery in vitro
2021
- 103Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage103
- Abstract Views102
- Plays1
Poster Description
Muscle atrophy is a prevalent condition that affects millions of individuals with an array of systemic and chronic diseases. As of today, there is no specific treatment to mitigate the effects of muscle atrophy. During this experiment, we utilized human cell lines obtained from the American Type Culture Collection (ATCC), home-constructed virus like particles (VLPs), and fluorescence imaging. The goal of this proposal is to examine the utility of muscle cell receptor-specific VLPs in delivering fluorescein isothiocyanate (FITC) to skeletal muscle cells in vitro. Our working hypothesis is that the specific constructs of VLP can be used to selectively target skeletal muscle tissue for therapeutic delivery.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know